Abstract
Background: Growing evidence suggests that autoimmune mechanism plays an important role in the pathogenesis of cardiomyopathy. The purpose of this study was to investigate whether passive transfer of IgG and/or lymphocytes from rabbits with autoimmune cardiomyopathy is able to reproduce cardiomyopathic changes in severe combined immunodeficiency (SCID) mice.
Methods and results: SCID mice were injected intraperitoneally with IgG and/or peripheral blood lymphocytes (PBL) from either rabbits immunized with both β1-adrenoceptor peptide and M2-muscarinic receptor peptide (β1+M2 group) or rabbits with adjuvant (N group). Thirty five SCID mice were divided into seven groups; N-IgG, N-PBL, N-IgG & PBL, (β1+M2)-IgG, (β1+M2)-PBL, (β1+M2)-IgG & PBL and control groups. Heart weight in three (β1+M2) groups were significantly increased. All mice in three (β1+M2) groups showed high titer of rabbit anti-β1 adrenocepter autoantibodies, and 4 mice in the (β1+M2)-PBL group and 3 mice in the (β1+M2)-IgG & PBL group showed a significant increase in titer of rabbit anti-M2-muscarinic receptor autoantibodies. Focal infiltration of inflammatory cells in the myocardium was observed in the (β1+M2)-IgG & PBL group. In the (β1+M2)-PBL group and (β1+M2)-IgG & PBL group, cardiomyocyte diameters were significantly increased. Some myocytes of the (β1+M2)-IgG & PBL group exhibited intracellular edema, clumps of Z-band and increased numbers of mitochondria by using electron microscopy.
Conclusion: Transfer of IgG and PBL from rabbits immunized with combined β1 and M2 peptides was able to reproduce the early stage of cardiomyopathic changes in SCID mice
Acknowledgements
This work is supported by Grant for Project Research from High-Technology Center of Kanazawa Medical University (H2004-8).